|
|
Volumn 32, Issue 6, 2005, Pages
|
|
The changing treatment paradigm in patients with newly diagnosed multiple myeloma: implications for nursing.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BISPHOSPHONIC ACID DERIVATIVE;
BONE DENSITY CONSERVATION AGENT;
IMMUNOLOGIC FACTOR;
AUTOTRANSPLANTATION;
CANCER STAGING;
DOSE RESPONSE;
HUMAN;
METHODOLOGY;
MULTIPLE MYELOMA;
NURSING;
ONCOLOGY NURSING;
PATHOLOGY;
PATHOPHYSIOLOGY;
REVIEW;
STEM CELL TRANSPLANTATION;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE DENSITY CONSERVATION AGENTS;
DIPHOSPHONATES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
IMMUNOLOGIC FACTORS;
MULTIPLE MYELOMA;
NEOPLASM STAGING;
ONCOLOGIC NURSING;
STEM CELL TRANSPLANTATION;
TRANSPLANTATION, AUTOLOGOUS;
MLCS;
MLOWN;
|
|
EID: 33646836979
PISSN: None
EISSN: 15380688
Source Type: Journal
DOI: 10.1188/05.onf.e127-e138 Document Type: Review |
|
Times cited : (9)
|
|
References (102)
|
